Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain
Primary Purpose
Pain, Pain, Postoperative, Pain, Acute
Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Technology Based Intervention Group 1
Technology Based Intervention Group 2
Sponsored by
About this trial
This is an interventional other trial for Pain
Eligibility Criteria
Inclusion Criteria:
- Ages 12 -18 years
- Scheduled to undergo surgery anticipated to cause moderate to severe pain with expected length of stay > or = to 2 days
- Able to read, understand and speak English
- Patients requiring management by the Acute Pain Service
- Possession of a mobile device/computer available for study participation
Exclusion Criteria:
- Outside the age range (< 12 or > 18 years)
- Non-English speaking
- History of significant developmental delay, uncontrolled psychiatric conditions associated with hallucinations or delusions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)
- History of vertigo, dizziness, seizure disorder, and/or severe motion sickness
- History of chronic pain
- Are chronically using opioids and or benzodiazepines for the management of pain
- Are actively experiencing nausea or vomiting
- Conditions such as craniofacial abnormalities or surgeries of the head and neck
- Previous participation in this study
Sites / Locations
- Nationwide Children's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Other
Other
Other
Arm Label
Technology Based Intervention 1 (Phase 1)
Technology Based Intervention 1 (Phase 2)
Technology Based Intervention 2 (Phase 2)
Arm Description
Outcomes
Primary Outcome Measures
Aim 1: Treatment protocol refinement
Frequency of sessions
Aim 1: Treatment protocol refinement
Duration of sessions
Aim 2: Feasibility of technology intervention in perioperative patients
Rate of study recruitment
Secondary Outcome Measures
Aim 1: Preoperative training protocol
Frequency of preoperative training session
Aim 1: Preoperative training protocol
Duration of preoperative training session
Aim 1: Post-operative session protocol
Frequency of post-operative intervention session
Aim 1: Post-operative session protocol
Duration of post-operative intervention session
Aim 2: Rate of study enrollment/randomization
Assessment of ability to enroll and randomize patients in pilot clinical trial
Aim 2: Rate of study retention
Assessment of ability to retain patients in pilot clinical trial
Aim 2: Rate of treatment adherence
Assessment of patient adherence to study protocol
Aim 2: Treatment-specific satisfaction
Qualitative feedback from participants using questionnaire to assess intervention satisfaction
Aim 2: Treatment-specific satisfaction
Qualitative feedback from participants using semi-structured interview to assess intervention satisfaction
Aim 2: Effect of technology on anxiety
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Aim 2: Effect of technology on medication use
Medications used will be collected
Aim 2: Effect of technology on anxiety
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Aim 2: Effect of technology on anxiety
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Aim 2: Effect of technology on pain
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Aim 2: Effect of technology on pain
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Aim 2: Effect of technology on pain
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Aim 2: Effect of technology on pain
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Aim 2: Self-Reported Outcomes
Semi-structured interview
Full Information
NCT ID
NCT04943874
First Posted
May 17, 2021
Last Updated
July 18, 2023
Sponsor
Vanessa Olbrecht
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
1. Study Identification
Unique Protocol Identification Number
NCT04943874
Brief Title
Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain
Official Title
Feasibility and Acceptability of a Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain in Children and Adolescents After Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
March 10, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
August 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Vanessa Olbrecht
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To develop and refine a technology based treatment protocol for preoperative education and training and postoperative care in children and adolescents undergoing surgery.
Detailed Description
This is a 2-phase study aimed to refine a perioperative treatment protocol for a technology-based intervention (Aim 1) and to understand whether technology-based interventions can be used to help treat pain in children following surgery (Aim 2). Patients will participate in only one phase of the study, and when patients are enrolled will determine what Phase of the study they are in.
In Phase 1, all patients will use the same technology, and no randomization will occur. Primary and secondary outcome measures of Aim 1 are assessed in Phase 1. Actual enrollment for Phase 1 was 23 patients.
In Phase 2, patients will be randomized to receive 1 of 2 technology-based interventions. The perioperative treatment protocol developed in Phase 1 (Aim 1) will be used in Phase 2 to assess the primary and secondary outcome measures of Aim 2. This phase is anticipated to enroll up to 70 participants.
This is not an FDA-regulated drug or device trial as the technology used in this study is categorized as a relaxation device by the FDA and considered "minimal risk", thus exempt from both NDE and IDE.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Pain, Postoperative, Pain, Acute, Surgery
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
93 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Technology Based Intervention 1 (Phase 1)
Arm Type
Other
Arm Title
Technology Based Intervention 1 (Phase 2)
Arm Type
Other
Arm Title
Technology Based Intervention 2 (Phase 2)
Arm Type
Other
Intervention Type
Device
Intervention Name(s)
Technology Based Intervention Group 1
Intervention Description
In Phase 1, all participants will use the same technology. In Phase 2, participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.
Intervention Type
Device
Intervention Name(s)
Technology Based Intervention Group 2
Intervention Description
Participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.
Primary Outcome Measure Information:
Title
Aim 1: Treatment protocol refinement
Description
Frequency of sessions
Time Frame
Duration of study up to 30 days
Title
Aim 1: Treatment protocol refinement
Description
Duration of sessions
Time Frame
Duration of study up to 30 days
Title
Aim 2: Feasibility of technology intervention in perioperative patients
Description
Rate of study recruitment
Time Frame
Pre-intervention
Secondary Outcome Measure Information:
Title
Aim 1: Preoperative training protocol
Description
Frequency of preoperative training session
Time Frame
Up to two weeks pre-operatively
Title
Aim 1: Preoperative training protocol
Description
Duration of preoperative training session
Time Frame
Up to two weeks pre-operatively
Title
Aim 1: Post-operative session protocol
Description
Frequency of post-operative intervention session
Time Frame
Up to two week post surgery
Title
Aim 1: Post-operative session protocol
Description
Duration of post-operative intervention session
Time Frame
Up to two weeks post surgery
Title
Aim 2: Rate of study enrollment/randomization
Description
Assessment of ability to enroll and randomize patients in pilot clinical trial
Time Frame
Pre-intervention
Title
Aim 2: Rate of study retention
Description
Assessment of ability to retain patients in pilot clinical trial
Time Frame
Duration of study up to 30 days
Title
Aim 2: Rate of treatment adherence
Description
Assessment of patient adherence to study protocol
Time Frame
Duration of study up to 30 days
Title
Aim 2: Treatment-specific satisfaction
Description
Qualitative feedback from participants using questionnaire to assess intervention satisfaction
Time Frame
Post intervention up to two weeks
Title
Aim 2: Treatment-specific satisfaction
Description
Qualitative feedback from participants using semi-structured interview to assess intervention satisfaction
Time Frame
Post intervention up to two weeks
Title
Aim 2: Effect of technology on anxiety
Description
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Time Frame
30 minutes after using technology
Title
Aim 2: Effect of technology on medication use
Description
Medications used will be collected
Time Frame
Duration of hospital stay (2-7 days)
Title
Aim 2: Effect of technology on anxiety
Description
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Time Frame
Before using technology
Title
Aim 2: Effect of technology on anxiety
Description
Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Time Frame
Immediately after using technology
Title
Aim 2: Effect of technology on pain
Description
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Time Frame
Preoperatively (up to 5 days)
Title
Aim 2: Effect of technology on pain
Description
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Time Frame
Before using technology
Title
Aim 2: Effect of technology on pain
Description
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Time Frame
Immediately after using technology
Title
Aim 2: Effect of technology on pain
Description
Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Time Frame
30 minutes after using technology
Title
Aim 2: Self-Reported Outcomes
Description
Semi-structured interview
Time Frame
Day of hospital discharge (Postoperatively 2-7 days)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Ages 12 -18 years
Scheduled to undergo surgery anticipated to cause moderate to severe pain with expected length of stay > or = to 2 days
Able to read, understand and speak English
Patients requiring management by the Acute Pain Service
Possession of a mobile device/computer available for study participation
Exclusion Criteria:
Outside the age range (< 12 or > 18 years)
Non-English speaking
History of significant developmental delay, uncontrolled psychiatric conditions associated with hallucinations or delusions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)
History of vertigo, dizziness, seizure disorder, and/or severe motion sickness
History of chronic pain
Are chronically using opioids and or benzodiazepines for the management of pain
Are actively experiencing nausea or vomiting
Conditions such as craniofacial abnormalities or surgeries of the head and neck
Previous participation in this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vanessa Olbrecht, MD
Organizational Affiliation
Nationwide Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nationwide Children's Hospital
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43205
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared with the public, but aggregate data will be publicly available upon request.
Learn more about this trial
Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain
We'll reach out to this number within 24 hrs